Which of the following is a progressive neurologic disorder characterized by degeneration of upper and lower motor neurons?
A.
Which of the following is disease in which patients may have facial wasting, hypotonia, an arched palate with progressive weakness that begins in the distal muscles?
B.
Which of the following is transmitted in X-linked, autosomal recessive, and autosomal dominant fashions in which patients typically exhibit muscle weakness and wasting in a scapulohumeroperoneal distribution?
C.
You are treating a patient with a proximal distribution of weakness. Which of the following NMD is most likely?
B.
Diagnosis of muscular dystrophy combines:
1.physical examination.
2.laboratory testing.
3.muscle biopsy findings.
4.pulmonary function testing.
D.
Which of the following NMD can be diagnosed with genetic testing of the dystrophin gene?
The use of hands and arms to “walk up” their own body from a squatting position is referred to as:
B.
Which of the following is early sign of disease seen in an infant with Duchenne muscular dystrophy?
A.
Which of the following are the two main categories of stroke?
B.
Which of the following areas involved in a stroke will cause sensory and motor impairment of the lower extremities?
A.
You are assisting the physician with the assessment of a patient that is thought to have ALS. What clinical cues should you be most aware of?
1.Sialorrhea
2.Muscle biopsy results
3.Tongue fasciculations
4.Nerve conduction study results
D.
Tissue plasminogen activator (TPa) should be administered within ________ of the onset of stroke symptoms.
B.
You are assessing the patient-ventilator system of a patient being treated for stroke. What parameters are you most concerned with during the assessment?
1.PEEP level of 20 cm H2O
2.Frequency of 18 breaths/min
3.MAP level of 30 mm Hg
4.Peak inspiratory pressure of 21 cm H2O
B.
The respiratory therapist can prevent increases in intracranial pressure (ICP) by:
B.
General management and care of a patient with neuromuscular disease includes: